Literature DB >> 18725330

Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures.

Irina Naletova1, Elena Schmalhausen, Aleksey Kharitonov, Aleksey Katrukha, Luciano Saso, Antonio Caprioli, Vladimir Muronetz.   

Abstract

Interactions between different forms of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and amyloid-beta peptide (1-42) were investigated by direct (surface plasmon resonance) and indirect (kinetics of spontaneous and GroEL/S-assisted reactivation of denatured GAPDH) methods. It was demonstrated that non-native forms of GAPDH obtained by different ways (cold denaturation, oxidation of the enzyme, and its unfolding in guanidine hydrochloride) efficiently bind to soluble amyloid-beta peptide (1-42) yielding a stable complex. Native tetrameric GAPDH does not interact with soluble amyloid-beta peptide (1-42), neither non-native forms of GAPDH interact with aggregated amyloid-beta peptide (1-42). The results suggest that non-native GAPDH species can be involved in the formation of amyloid structures during Alzheimer's disease, binding to soluble amyloid-beta peptide (1-42).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725330     DOI: 10.1016/j.bbapap.2008.07.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  A proteomic approach for the involvement of the GAPDH in Alzheimer disease in the blood of Moroccan FAD cases.

Authors:  Nadia El Kadmiri; Raquel Cuardos; Bouchra El Moutawakil; Ilham Slassi; Jesus Avila; Sellama Nadifi; Ahmed Hachem; Abdelaziz Soukri
Journal:  J Mol Neurosci       Date:  2014-07-15       Impact factor: 3.444

Review 2.  Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.

Authors:  D Allan Butterfield; Sarita S Hardas; Miranda L Bader Lange
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Lessons learned from protein aggregation: toward technological and biomedical applications.

Authors:  César L Avila; Silvina Chaves; Sergio B Socias; Esteban Vera-Pingitore; Florencia González-Lizárraga; Cecilia Vera; Diego Ploper; Rosana Chehín
Journal:  Biophys Rev       Date:  2017-09-13

Review 4.  Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer's disease.

Authors:  Xue-Mei Gu; Han-Chang Huang; Zhao-Feng Jiang
Journal:  Neurosci Bull       Date:  2012-09-12       Impact factor: 5.203

5.  The amyloid precursor protein affects glyceraldehyde 3-phosphate dehydrogenase levels, organelle localisation and thermal stability.

Authors:  Alexandré Delport; Stefan Kins; Raymond Hewer
Journal:  Mol Biol Rep       Date:  2020-03-09       Impact factor: 2.316

6.  Differential expression of proteins in brain regions of Alzheimer's disease patients.

Authors:  Saadia Zahid; Michael Oellerich; Abdul R Asif; Nikhat Ahmed
Journal:  Neurochem Res       Date:  2013-12-04       Impact factor: 3.996

7.  Testis-specific glyceraldehyde-3-phosphate dehydrogenase: origin and evolution.

Authors:  Mikhail L Kuravsky; Vladimir V Aleshin; Dmitrij Frishman; Vladimir I Muronetz
Journal:  BMC Evol Biol       Date:  2011-06-10       Impact factor: 3.260

8.  The effects of endogenous non-peptide molecule isatin and hydrogen peroxide on proteomic profiling of rat brain amyloid-β binding proteins: relevance to Alzheimer's disease?

Authors:  Alexei E Medvedev; Olga A Buneeva; Arthur T Kopylov; Oksana V Gnedenko; Marina V Medvedeva; Sergey A Kozin; Alexis S Ivanov; Victor G Zgoda; Alexander A Makarov
Journal:  Int J Mol Sci       Date:  2014-12-29       Impact factor: 5.923

9.  Extracellular GAPDH Promotes Alzheimer Disease Progression by Enhancing Amyloid-β Aggregation and Cytotoxicity.

Authors:  Vladimir F Lazarev; Magda Tsolaki; Elena R Mikhaylova; Konstantin A Benken; Maxim A Shevtsov; Alina D Nikotina; Mirna Lechpammer; Vladimir A Mitkevich; Alexander A Makarov; Alexey A Moskalev; Sergey A Kozin; Boris A Margulis; Irina V Guzhova; Evgeny Nudler
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

10.  Factors Affecting Aggregate Formation in Cell Models of Huntington's Disease and Amyotrophic Lateral Sclerosis.

Authors:  V F Lazarev; D V Sverchinskyi; M V Ippolitova; A V Stepanova; I V Guzhova; B A Margulis
Journal:  Acta Naturae       Date:  2013-04       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.